Identification of a novel class of cortisol biosynthesis inhibitors and its implications in a therapeutic strategy for hypercortisolism
Home »
Publications » Identification of a novel class of cortisol biosynthesis inhibitors and its implications in a therapeutic strategy for hypercortisolism
Publish Date 12/21/2024
Category
Keywords
Identification of a novel class of cortisol biosynthesis inhibitors and its implications in a therapeutic strategy for hypercortisolism
Join the Arbor Assays Newsletter
Sign up for Arbor Assays’ email list to stay up to date on special deals, new kits, and published articles featuring Arbor Assays’ products
